Crossmark

Local cranial radiation combined with third-generation tyrosine kinase inhibitors improve leptomeningeal metastasis disease-free survival in patients with EGFR-mutated non-small cell lung cancer and brain metastasis

Crossref DOI link: https://doi.org/10.1007/s11060-025-05045-6

Published Online: 2025-06-18

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Qian

Wang, Hui

Hong, Weiping

Bashir, Shoaib

Hua, Xiaoyu

Yang, Yanying

Zhen, Junjie

Li, Juan

Lai, Mingyao

Cai, Linbo
Funding

Funding for this research was provided by:

Guangdong Sanjiu Brain Hospital (No. B392024005, No. A392024009, No. A392024002, No. C392024021)
License Information

Text and Data Mining valid from 2025-06-18

Version of Record valid from 2025-06-18
More Information

Article History

Received: 12 March 2025

Accepted: 9 April 2025

First Online: 18 June 2025

Declarations

:

: This retrospective study was approved by the Ethics Committee of the Guangdong Sanjiu Brain Hospital (No.2024-01-019), and there was informed consent exemption for all patients.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below